66 related articles for article (PubMed ID: 32732186)
1. Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.
Kalmi G; Nguyen Y; Amarger S; Aubineau M; Bibes B; Blanchard-Delaunay C; Boccon-Gibod I; Bouillet L; Coppo P; Dalmas MC; Debord-Peguet S; Defendi F; Demoreuil C; Du-Thanh A; Gayet S; Hadjadj J; Jeandel PY; Launay D; Ly KH; Avoy CM; Niault M; Ollivier Y; Pelletier F; Porneuf M; Roos-Weil D; Fain O; Gobert D
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):212-222. PubMed ID: 37844846
[TBL] [Abstract][Full Text] [Related]
2. An Overview of Hereditary Angioedema for the Primary Care Physician.
Sarkar A; Nwagwu C; Craig T
Med Clin North Am; 2024 Jul; 108(4):747-755. PubMed ID: 38816115
[TBL] [Abstract][Full Text] [Related]
3. What lessons are learned?: Our changing practice during 30 years of hereditary angioedema treatment.
Keskin S; Pak Y; Celestin J
Ann Allergy Asthma Immunol; 2024 Jun; 132(6):774-776. PubMed ID: 38403158
[No Abstract] [Full Text] [Related]
4. Subcutaneous C1 Inhibitor for Long-term Prophylaxis of Hereditary Angioedema: A Real-life Experience.
Baynova K; Cimbollek S; Quiralte J; García R; Lucena JM; Lasa Luaces E; Lara Jiménez MA; Alvarez Nieto J; Moreto J; González-Quevedo T
J Investig Allergol Clin Immunol; 2024 Jun; 34(3):198-199. PubMed ID: 37796634
[No Abstract] [Full Text] [Related]
5. Evaluation of the safety and effectiveness of berotralstat for patients with hereditary angioedema: Report of six cases.
Takamura S; Nakamura K; Fukuda T
J Dermatol; 2023 Nov; 50(11):1506-1508. PubMed ID: 37721445
[No Abstract] [Full Text] [Related]
6. Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedema.
Schlueter M; Nestler-Parr S
J Comp Eff Res; 2024 May; 13(5):e230165. PubMed ID: 38545965
[No Abstract] [Full Text] [Related]
7. Hereditary Angioedema: A Test of Our Progress.
Christiansen SC; Zuraw BL
J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3211-3212. PubMed ID: 37805224
[No Abstract] [Full Text] [Related]
8. Acquired angioedema: an unusual presentation of haematological malignancy.
Farrugia D; Caruana Dingli M; Grech M
BMJ Case Rep; 2022 Sep; 15(9):. PubMed ID: 36123007
[TBL] [Abstract][Full Text] [Related]
9. Hereditary angioedema and thrombosis.
Gailani D
Blood; 2023 May; 141(19):2295-2297. PubMed ID: 37166925
[No Abstract] [Full Text] [Related]
10. Stroke-like manifestations of angioedema: A case report and the identification of a novel mutation.
Karam JD; Boulu X; Hardy G; Buron Y
Rev Neurol (Paris); 2024 May; 180(5):465-467. PubMed ID: 38042664
[No Abstract] [Full Text] [Related]
11. Life-threatening Idiopathic Nonhistaminergic Acquired Angioedema With Response to Lanadelumab.
Gamboa P; Galán C; Arrien A; Segurola A; Jáuregui I
J Investig Allergol Clin Immunol; 2024 Feb; 34(1):68-70. PubMed ID: 37403773
[No Abstract] [Full Text] [Related]
12. 13th C1-inhibitor deficiency and angioedema workshop-2023 : Edited by: Róbert Hohol; Lectored by: Henriette Farkas, Lilian Varga; Cover artwork: Gergely Hosszú.
Allergy Asthma Clin Immunol; 2023 Dec; 19(Suppl 1):106. PubMed ID: 38124188
[No Abstract] [Full Text] [Related]
13. Changes of Motile Ciliary Phenotype in Patients with Primary Ciliopathies.
Brndiarova M; Kvassayova J; Vojtkova J; Igaz M; Buday T; Plevkova J
Adv Exp Med Biol; 2021; 1335():79-85. PubMed ID: 33687727
[TBL] [Abstract][Full Text] [Related]
14. Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency.
Polai Z; Balla Z; Varga L; Benedek S; Farkas H
Heliyon; 2022 Nov; 8(11):e11292. PubMed ID: 36387475
[TBL] [Abstract][Full Text] [Related]
15. Successful Use of Recombinant Human C1-INH in a Patient with Acquired Angioedema due to C1 Inhibitor Deficiency and an Unusually High Titer of Anti-C1-Inhibitor Autoantibodies.
Jesenak M; Brndiarova M; Banovcin P; Varga L; Farkas H
J Investig Allergol Clin Immunol; 2021 Jun; 31(3):255-256. PubMed ID: 32732186
[No Abstract] [Full Text] [Related]
16. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity.
Wu MA; Castelli R
Clin Chem Lab Med; 2016 Feb; 54(2):207-14. PubMed ID: 26068904
[TBL] [Abstract][Full Text] [Related]
17. Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate.
Bork K; Staubach-Renz P; Hardt J
Orphanet J Rare Dis; 2019 Mar; 14(1):65. PubMed ID: 30866985
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
[TBL] [Abstract][Full Text] [Related]
19. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
